|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.56 USD | +2.19% |
|
+9.52% | -10.03% |
| 03-10 | Legend Biotech Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 | CI |
| 03-10 | Legend Biotech Corporation, Q4 2025 Earnings Call, Mar 10, 2026 |
| Capitalization | 3.61B 3.1B 2.8B 2.68B 4.9B 332B 5.06B 33.03B 13.22B 159B 13.56B 13.27B 570B | P/E ratio 2025 |
-13.4x | P/E ratio 2026 * | 81.5x |
|---|---|---|---|---|---|
| Enterprise value | 3.27B 2.8B 2.53B 2.43B 4.43B 300B 4.57B 29.86B 11.96B 144B 12.26B 12B 515B | EV / Sales 2025 |
3.9x | EV / Sales 2026 * | 1.93x |
| Free-Float |
98.8% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Legend Biotech Corporation
| 1 day | +2.19% | ||
| 1 week | +9.52% | ||
| Current month | +2.95% | ||
| 1 month | +9.21% | ||
| 3 months | -16.27% | ||
| 6 months | -41.56% | ||
| Current year | -10.03% |
| 1 week | 17.46 |  | 19.98 |
| 1 month | 17.46 | | 21.58 |
| Current year | 16.24 | | 24.12 |
| 1 year | 16.24 | | 45.3 |
| 3 years | 16.24 | | 77.32 |
| 5 years | 16.24 | | 77.32 |
| 10 years | 16.24 | | 77.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 53 | 2020-09-20 |
Mythili Koneru
CTO | Chief Tech/Sci/R&D Officer | 48 | 2023-04-10 |
Tracy Luo
CTO | Chief Tech/Sci/R&D Officer | - | 2018-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ye Wang
CHM | Chairman | 57 | 2020-11-05 |
Ying Huang
BRD | Director/Board Member | 53 | 2021-12-29 |
Corazon Sanders
BRD | Director/Board Member | 69 | 2020-04-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.19% | +9.52% | -42.52% | -54.95% | 3.61B | |
| +0.13% | -0.34% | +22.41% | +96.32% | 45.56B | |
| +3.35% | +0.43% | +51.85% | +17.36% | 40.81B | |
| +0.50% | -2.14% | +96.87% | +700.06% | 31.01B | |
| -17.88% | -16.74% | -20.37% | -34.18% | 21.05B | |
| -1.42% | +2.27% | +49.79% | -28.09% | 19.37B | |
| -1.56% | -1.81% | +27.42% | -29.36% | 17.15B | |
| -0.09% | +20.57% | +62.75% | +189.79% | 13.54B | |
| +3.88% | +8.07% | -9.23% | +995.97% | 12.66B | |
| -1.79% | +16.72% | +65.93% | - | 12.33B | |
| Average | -1.27% | +3.37% | +30.49% | +205.88% | 21.71B | |
| Weighted average by Cap. | -1.10% | +0.95% | +39.33% | +195.45% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 1.03B 889M 803M 769M 1.4B 95.05B 1.45B 9.46B 3.79B 45.57B 3.88B 3.8B 163B | 1.44B 1.24B 1.12B 1.07B 1.95B 132B 2.02B 13.16B 5.27B 63.38B 5.4B 5.29B 227B |
| Net income | -270M -232M -210M -201M -366M -24.8B -378M -2.47B -988M -11.89B -1.01B -992M -42.56B | 34.34M 29.49M 26.66M 25.52M 46.61M 3.15B 48.08M 314M 126M 1.51B 129M 126M 5.41B |
| Net Debt | -347M -298M -269M -258M -471M -31.85B -486M -3.17B -1.27B -15.27B -1.3B -1.27B -54.68B | -838M -719M -650M -623M -1.14B -76.95B -1.17B -7.66B -3.07B -36.89B -3.14B -3.08B -132B |
Employees
3,000
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-10 | 19.56 $ | +2.19% | 1,626,059 |
| 26-03-09 | 19.14 $ | +0.90% | 1,380,495 |
| 26-03-06 | 18.97 $ | +6.87% | 1,879,222 |
| 26-03-05 | 17.75 $ | -0.56% | 1,655,657 |
| 26-03-04 | 17.85 $ | -0.06% | 1,660,175 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
19.56USD
Average target price
58.40USD
Spread / Average Target
+198.59%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LEGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition